4
Changes in Ownership
ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-21-011312
CEO gave up 173,241 shares (to pay taxes)
- CEO acquired 75,880 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Shah Gaurav · CEO
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-30 | Shares withheld for taxes : show line 1 in the form | −19,984 | $41.80 | $835,329 | 614,092 | D |
| 2021-03-30 | Shares withheld for taxes : show line 2 in the form | −8,667 | $42.80 | $370,906 | 594,108 | D |
| 2021-03-30 | Shares withheld for taxes : show line 3 in the form | −48,732 | $43.86 | $2,137,152 | 545,376 | D |
| 2021-03-30 | Shares withheld for taxes : show line 4 in the form | −8,505 | $44.34 | $377,105 | 536,871 | D |
| 2021-03-31 | Exercise or conversion : show line 5 in the form | +75,880 | $1.69 | $128,237 | 612,751 | D |
| 2021-03-31 | Shares withheld for taxes : show line 6 in the form | −3,000 | $45.59 | $136,770 | 609,751 | D |
| 2021-03-31 | Shares withheld for taxes : show line 7 in the form | −61,350 | $44.24 | $2,714,320 | 548,401 | D |
| 2021-03-31 | Shares withheld for taxes : show line 8 in the form | −23,003 | $45.06 | $1,036,557 | 525,398 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-03-31 | Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) | −75,880 | $1.69 | 2027-04-12 | 75,880 | 0 | D |
Loading xslF345X03/form4.xml…